Global strategy on digital health 2020-2025 ISBN 978-92-4-002092-4 (electronic version) ISBN 978-92-4-002093-1 (print version) © World Health Organization 2021 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercialShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial […]
Read MoreJuly 2, 2025

COMPREHENSIVE IMPLEMENTATION PLAN ON MATERNAL, INFANT AND YOUNG CHILD NUTRITION
© World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce […]
Read MoreJuly 2, 2025

Seventy-eighth World Health Assembly 2025 – Consolidated report by the Director-General
Pillar 4: More effective and efficient WHO providing better support to countries 11. Review of and update on matters considered by the Executive Board 11.1 Governance reform → Secretariat implementation plan on reform (decision WHA75(8) (2022)) 1. The Executive Board at its 156th session noted the report on the Secretariat implementation plan on reform2 and […]
Read MoreJuly 2, 2025

World report on vision
World report on vision ISBN978-92-4-151657-0 © World Health Organization 2019 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated […]
Read MoreJuly 2, 2025

Seventy-eighth World Health Assembly – Daily update: 23 May 2025
New guideline calls for improved global access to controlled medicines The World Health Organization (WHO) has released a rapid communication outlining its new guideline on balanced national policies for controlled medicines. The guideline was officially presented during a high-level side event at the Seventy-eighth World Health Assembly. It is designed to support countries in ensuring […]
Read MoreJuly 2, 2025

Primary prevention and integrated care for sensory impairments including vision impairment and hearing loss, across the life course
The Executive Board, having considered the report by the Director-General, Decided to recommend to the Seventy-eighth World Health Assembly the adoption of the following resolution: → The Seventy-eighth World Health Assembly, → Having considered the report by the Director-General; Having considered also the World report on vision2 and the World report on hearing3 and recalling […]
Read MoreJuly 2, 2025

WHO statement on menstrual health and rights
50th session of the Human Rights Council Panel discussion on menstrual hygiene management, human rights and gender equality Menstrual Health is firmly on the global agenda today. Menstrual Health was not on the agenda of the International Conference on the Population and Development or the Millennium Declaration. Nor it is explicitly stated in the Sustainable […]
Read MoreJuly 2, 2025

FDA’s Rare Disease Innovation Hub Releases 2025 Strategic Agenda
The FDA’s Rare Disease Innovation Hub (Hub) has released its Strategic Agenda, detailing its first-year actions and engagement with the rare disease community while clarifying its structure and programs. The Hub fosters collaboration between the Center for Biologics Evaluation and Research (CBER) and the Center for Drug Evaluation and Research (CDER) to enhance rare disease […]
Read MoreFebruary 24, 2025
Research Progress Related to albinism
Research on albinism is crucial for improving the quality of life, health, and social inclusion of individuals with this condition. By studying the genetic causes and visual impairments associated with albinism, such as nystagmus and reduced melanin affecting vision and skin protection, researchers can develop targeted treatments and interventions. Advances in understanding albinism also help […]
Read MoreDecember 8, 2024

Research Progress Related to Vitiligo
Research on vitiligo provides significant benefits, advancing understanding of this complex autoimmune skin condition that causes patches of skin to lose pigment. By investigating the genetic, immunological, and environmental factors involved, researchers can develop more effective treatments and potential cures, improving quality of life for those affected. Additionally, research helps to raise awareness, reduce stigma, […]
Read MoreDecember 8, 2024
The Annual Open Enrollment for Medicare began on October 15 and ends on December 7, 2024 for coverage beginning January 1, 2025. The CSD, in partnership with the Medicare Access for Patients Rx (MAPRx) Coalition, has created a Medicare Part D prescription drug open enrollment guide and patient guide for our members, as well as an infographic. Congress recently made changes to […] October 28, 2024
2025 Medicare Enrollment Resources